Multiple Sclerosis Drugs Market to Exhibit 6.7% CAGR, Leading Companies Focus on Strategic Collaborations to Expand Their Footprint
The Global Multiple Sclerosis Drugs Market is expected to gain from the development of economical therapy to treat multiple sclerosis (MS), finds Fortune Business Insights in a report, titled "MULTIPLE SCLEROSIS DRUGS: GLOBAL MARKET ANALYSIS, INSIGHTS, AND FORECAST, 2019-2026." According to the report, the global market was worth US$ 23,460.3 Mn in 2018. The market is anticipated to expand at a CAGR of 6.7% and reach US$ 39,289.5 Mn by the end of 2026. The report offers a comprehensive overview...
View full press release